The 7 analysts offering 12-month price forecasts for NextCure Inc have a median target of 17.00, with a high estimate of 27.00 and a low estimate of 7.00. The median estimate represents a +196.68% increase from the last price of 5.73.
The current consensus among 8 polled investment analysts is to Buy stock in NextCure Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.67
Reporting Date Mar 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.